Beijing Allwin Pharmaceutical Technology Co., Ltd is the leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on healthy and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients.
Allwin is headquartered in Beijing, China, with 6 approved products on the market, including rhEGF,rhPDGF-BB,rhIL-1Ra,r-SAK,SOD,GMCSF.
Allwin's core product, Allwin(rhEGF) has been the leading brand of rhEGF in China with a dominant 70% of the market share. Allwin's profitability has been ranked No. 1 among Chinese biopharmaceutical companies.